News
British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...
Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...
Advent International has had its improved £4.8bn takeover offer for British scientific instruments maker Spectris accepted by ...
Precision instrument maker Spectris has agreed to be bought by Advent International after it trumped an offer from US ...
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease ...
Advent International said it increased its takeover bid for precision-measurement company Spectris to 4.2 billion pounds ($5.55 billion).
Advent’s increased offer represents a 2.5 percent increase to the KKR offer. This means the shareholders will receive an additional £1.00 per share, amounting to a total increase of £101.5 million ...
The firm is acting for the Just Group in its £2.4 billion sale, a month after it helped conclude the sale of Spectris to a ...
One of Wescom’s appeals for Sun European was the mandatory cycle of product replacement, according to Wyndham. “They are ...
British scientific instruments maker Spectris has agreed to private equity firm Advent's sweetened takeover bid valued at 4.8 billion pounds ($6.38 billion), including debt, the companies said on ...
Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.
6d
Medical Device Network on MSNAAIC25: Cognito neuromodulation therapy slows decline in Alzheimer’s diseaseCognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter in patients with mild to moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results